by Market Overview:
Aptamers are synthetic single-stranded nucleic acid or peptide molecules that bind to a specific target with high affinity and selectivity. They are oligonucleotides or peptides that bind to disease biomarkers or therapeutic drug targets and may have applications in disease diagnostics, drug discovery, and targeted therapeutics. Aptamers have emerged as a robust diagnostic tool with advantageous properties such as high target specificity and affinity, design versatility, low cost of development, and production scalability.
Market Dynamics:
The aptamers market is primarily driven by increasing investments in research and development activities related to aptamer-based therapeutics and diagnostics. Various biotech and pharmaceutical companies are investing heavily in developing novel aptamer-based therapeutics and diagnostic tools. For instance, NeoNeuro SAS raised USD 11 million in funding in 2019 to advance its aptamer-based Neurology pipeline. Furthermore, rising demand for personalized medicine is also contributing to the market growth. Aptamers find extensive use in facilitating precision medicine due to their high affinity and specificity for molecular targets. Their ability to specifically bind to disease biomarkers makes them suitable for developing targeted therapeutics and precision diagnostics. Another driver for the market is increasing acceptance of aptamers as alternatives to antibodies. Aptamers demonstrate comparable affinity and specificity to antibodies but with added advantages such as smaller size, easier production process, and prolonged shelf life at ambient temperature.
The global Aptamers Market Share is estimated to be valued at US$ 6265.49 Mn in 2023 and is expected to exhibit a CAGR of 18.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights
Segment Analysis
The global aptamers market is dominated by diagnostics sub segment. Aptamers are increasingly being used for diagnostic applications such as disease detection, toxin detection, food safety testing and others due to their high affinity and specificity for molecular recognition. The diagnostics sub segment occupied more than 35% of the total market share in 2023 due to rising demand for rapid, cost effective and accurate diagnostics.
PEST Analysis
Political: Governments across various countries are supporting research and development activities in the aptamers market. For instance, favorable regulations and increased funding for biotech and healthcare research promotes the development of new aptamer-based diagnostic kits and assays.
Economic: The growth of the global economy and rising healthcare spending increases the demand for advanced medical technologies like aptamers. The development of low-cost and rapid aptamer-based tests for point-of-care applications further drives the market growth.
Social: Increasing public awareness about early disease detection and rising adoption of personalized medicine are the key social factors contributing to the aptamers market expansion.
Technological: Continuous technological advancements in fields such as combinatorial chemistry, in vitro selection techniques and biosensor technologies have enhanced the potential of aptamers in diagnostic, analytic and therapeutic applications. Development of high-throughput aptamer selection protocols improves the production of aptamers.
The global Aptamers Market Share is estimated to be valued at US$ 6265.49 Mn in 2023 and is expected to exhibit a CAGR of 18.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights
Key Takeaways
The global aptamers market is expected to witness high growth, exhibiting CAGR of 18. over the forecast period, due to increasing demand for cost effective and rapid detection technologies. The market size for aptamers was valued at US$ 6265.49 Mn in 2023.
Regional analysis: North America dominated the global aptamers market and occupied over 40% share in 2023 owing to rising R&D investments, growing biotechnology industry and increasing funding for development of advanced medical technologies in the US and Canada. Asia Pacific is projected to be the fastest growing market during the forecast period driven by growing healthcare industry, rising medical expenditures and increasing governmental support for bio-technology advancements in India, China and Japan.
Key players: Key players operating in the aptamers market are Ophthotech Corporation, Aptamer Sciences, Inc., Novartis AG, NeoNeuro SAS, Aptagen LLC, Aptus Biotech S.L., AM Biotechnologies, LLC, Base Pair Biotechnologies, Vivonics Inc., CAGE Bio Inc., TAGCyx Biotechnologies Inc., AstraZeneca, GlyTech, Inc., GC Biopharma Corp., Achiko AG, Agilent Technologies, Inc., SomaLogic Operating Co., Inc., Amsbio, and IVERIC bio, Inc. These players are focusing on expanding their product portfolios through mergers & acquisitions and new product launches catering to untapped opportunities in the market.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
